John A Lewicki Net Worth & Insider Trades

John A Lewicki - President and CEO, Oncomed Pharmaceuticals Inc

As of April 23, 2019

What is John A Lewicki's Net Worth?

The current estimated net worth of Oncomed Pharmaceuticals Inc's President and CEO, John A Lewicki, is estimated to be about $1.83M . John A Lewicki owns about 155,354 units of Oncomed Pharmaceuticals Inc common stock. In the last 5 years at Oncomed Pharmaceuticals Inc, John A Lewicki has sold an estimated value of $1.83M worth.

What is John A Lewicki's Past Insider Trading?

John A Lewicki's largest purchase order was 17,000 units , worth over $30.08K on June 17, 2015. John A Lewicki's largest sale order was 17,000 units , worth over $429.71K on April 3, 2015. In total, John A Lewicki has made about 27 transactions over 5 years of their time at Oncomed Pharmaceuticals Inc. John A Lewicki usually trades in October, with the busiest year in 2014. The most recent transaction was a sale order of 1,156 units , worth over $2.32K on October 11, 2018.

John A Lewicki

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was John A Lewicki's Salary in 2017?

As President and CEO of Oncomed Pharmaceuticals Inc, John A Lewicki has a total base salary of $419,777 . John A Lewicki received compensation valued at about $1,748,288 in 2017 after becoming President and CEO. The vast majority of their compensation came in the form of stock awards of $192,925 , option awards of $967,675 , and other earnings, plans or compensations of $167,911 .

What is John A Lewicki's' Mailing Address?

  • Mailing address is C/o Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 CA

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

What are Oncomed Pharmaceuticals Inc's Past Insider Trades?

Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel .

OncoMed Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1